Differential Response to Interleukin-1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction

Saved in:
Bibliographic Details
Published inJournal of the American Heart Association Vol. 12; no. 18; p. e031251
Main Authors Golino, Michele, Moroni, Francesco, Carbone, Salvatore, Corna, Giuliana, Trankle, Cory, Billingsley, Hayley E, Del Buono, Marco G, Talasaz, Azita H, Thomas, Georgia K, De Ponti, Roberto, Turlington, Jeremy, Markley, Roshanak, Arena, Ross, Canada, Justin M, Van Tassell, Benjamin, Abbate, Antonio
Format Journal Article
LanguageEnglish
Published England John Wiley and Sons Inc 19.09.2023
Wiley
Subjects
anakinra
cardiopulmonary exercise test
Cardiorespiratory Fitness
diastolic
heart failure
Heart Failure - drug therapy
Humans
Interleukin 1 Receptor Antagonist Protein - therapeutic use
interleukin‐1
Research Letter
Research Letters
Stroke Volume
Ventricular Function, Left
anakinra
heart failure
interleukin‐1
diastolic
cardiopulmonary exercise test
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-1
content type line 63
ObjectType-Correspondence-2
This article was sent to Sakima A. Smith, MD, MPH, Associate Editor, for review by expert referees, editorial decision, and final disposition.
Drs M. Golino and F. Moroni contributed equally.
An abstract of this work was presented at the European Society of Cardiology Congress, August 25 to 28, 2023.
For Sources of Funding and Disclosures, see page 4.
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.123.031251